Evidence map›Paper›PMID 30720121›Full record

ArticleMolecular medicine reports2019

Identification of a pathogenic mutation in a Chinese pedigree with polycystic kidney disease.

Kexian Dong, Huanhuan Miao, Xueyuan Jia, Jie Wu, Han Wu, Jiawei Sun, Wei Ji, Hui Su, Lidan Xu, Xuelong Zhang and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Kexian DongLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Huanhuan MiaoIn‑Patient Ultrasound Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
Xueyuan JiaLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Jie WuLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Han WuIn‑Patient Ultrasound Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
Jiawei SunIn‑Patient Ultrasound Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
Wei JiLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Hui SuLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Lidan XuLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Xuelong ZhangLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Siqi ZhuLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Guohua JiLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Rongwei GuanLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Hao WangDepartment of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
Jing BaiLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Jingcui YuScientific Research Centre, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
Wenjing SunLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Xianli ZhouIn‑Patient Ultrasound Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
Songbin FuLaboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic kidney disease (PKD) is a life‑threatening inherited disease with a morbidity of 1:500‑1,000 worldwide. Numerous progressively enlarging cysts are observed in the bilateral kidneys of patients with PKD, inducing structural damage and loss of kidney function. The present study analyzed one family with PKD. Whole exome sequencing of the proband was performed to detect the pathogenic gene present in the family. Candidate gene segments for lineal consanguinity in the family were amplified by nest polymerase chain reaction, followed by Sanger sequencing. One novel duplication variant (NM_001009944.2:c.9359dupA:p.Y3120_E3121delinsX) and one missense mutation (c.G9022A:p.V3008M) were detected in PKD1. Additionally, the pathogenic substitutions in PKD1 published from the dataset were analyzed. Following analysis and confirmation, the duplication variant NM_001009944.2:c.9359dupA:p.Y3120_E3121delinsX in PKD1, within the polycystin‑1, lipoxygenase, α‑toxin domain, was considered to be the pathogenic factor in the examined family with autosomal dominant PKD. Additionally, based on the analysis of 4,805 pathogenic substitutions in PKD1 within various regions, the presence of the missense mutation in the N‑terminal domain of polycystin‑1 may present high pathogenicity in ADPKD.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseMutationAdultExome SequencingFemaleGene DuplicationGenotypeHumansMiddle AgedPedigreePolycystic Kidney DiseasesTRPP Cation ChannelsTRPP Cation Channels

Identifiers

PMID30720121
PMCPMC6423614
OpenAlexW2913429142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.